[Nongenomic effects of glucocorticoids, an important mechanism of inhaled glucocorticoids action in asthma].

Journal Title: Advances in Respiratory Medicine - Year 2009, Vol 77, Issue 5

Abstract

Authors describe the clinical implications of nongenomic effects of glucocorticoids, important also for the inhaled drugs. Data suggest that these rapid actions of glucocorticoids are important in the pharmacotherapy of asthma, particularly for prevention and treatment of acute exacerbations. Their influence on remodeling is also considered.

Authors and Affiliations

Alicja Grzanka, Jerzy Jarzab

Keywords

Related Articles

The prevalence of smoking among the population in the city of Mashhad (north east of Iran) and pulmonary function tests among smokers.

Introduction: Smoking is known as a major cause of chronic obstructive pulmonary disease (COPD). In this study the prevalence of smoking in the population of Mashhad city was evaluated as well as pulmonary function tests...

[The influence of inflammatory process on the ventilatory impairment in patients with stable chronic obstructive pulmonary disease].

At present, COPD is known to be a systemic disease resulting from generalized inflammation which affects the function of many organs. Generalized inflammation is recognized from increased serum concentration of inflammat...

[D-dimer in diagnosis and treatment of pulmonary embolism].

D-dimer level estimation, specific fibrin degradation product, is a permanent part of diagnostic strategies of pulmonary embolism (PE). Approximately 30% of a suspected non-high risk PE can be ruled out with high sensiti...

Download PDF file
  • EP ID EP85133
  • DOI -
  • Views 80
  • Downloads 0

How To Cite

Alicja Grzanka, Jerzy Jarzab (2009). [Nongenomic effects of glucocorticoids, an important mechanism of inhaled glucocorticoids action in asthma].. Advances in Respiratory Medicine, 77(5), 453-459. https://europub.co.uk/articles/-A-85133